Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer
IC Name
NATIONAL CANCER INSTITUTE
-
Activity
R44
-
Administering IC
CA
-
Application Type
4
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
1165750
-
Sub Project Total Cost
-
ARRA Funded
False
-
CFDA Code
395
-
Ed Inst. Type
-
Funding ICs
NCI:1165750\
-
Funding Mechanism
SBIR-STTR RPGs
-
Study Section
ZRG1
-
Study Section Name
Special Emphasis Panel